Eam Global Investors LLC Mirati Therapeutics, Inc. Transaction History

Eam Global Investors LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 10, 2020	SELL	$70.76 - $128.86 $650,001 - $1.18 Million	-9,186 Closed	0 $0
Q3 2019 Nov 13, 2019	SELL	$77.91 - $109.6 $1.23 Million - $1.73 Million	-15,795 Reduced 63.23%	9,186 $716,000
Q2 2019 Aug 14, 2019	SELL	$59.49 - $104.71 $238,554 - $419,887	-4,010 Reduced 13.83%	24,981 $2.57 Million
Q1 2019 May 10, 2019	BUY	$43.65 - $78.95 $1.27 Million - $2.29 Million	28,991 New	28,991 $2.13 Million
Q4 2018 Feb 13, 2019	SELL	$32.0 - $47.43 $776,320 - $1.15 Million	-24,260 Closed	0 $0
Q3 2018 Nov 08, 2018	SELL	$47.1 - $62.7 $227,916 - $303,405	-4,839 Reduced 16.63%	24,260 $1.14 Million
Q2 2018 Aug 03, 2018	SELL	$26.05 - $52.4 $188,497 - $379,166	-7,236 Reduced 19.91%	29,099 $1.44 Million
Q1 2018 Jun 04, 2018	BUY	$17.2 - $34.95 $624,962 - $1.27 Million	36,335 New	36,335 $1.12 Million

3.57M

36.6K

Ticker MRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,609,800
Description
Mirati Therapeutics, Inc., a clinical-stage oncology company, develops product candidates to address the genetic and immunological promoters of cancer in the United States. The company develops MRTX849, a KRAS G12C inhibitor, which is in Phase 1/2 clinical trial for treating non-small cell lung (NSCL), colorectal, pancreatic, and other cancers; ...

Get notified when there are updates to the investment portfolio of Eam Global Investors LLC, based on Form 13F filings with the SEC.

Stay updated on Eam Global Investors LLC with notifications on news.